查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1586128

心肺自動輸血系統市場：按產品、應用和最終用戶 - 全球預測 2025-2030

Cardiopulmonary Autotransfusion Systems Market by Product (Off-Pump Transfusion Device, On-Pump Transfusion Device), Application (Cardiac Surgery, Organ Transplant, Orthopedic Surgery), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年心肺自動輸血系統市場價值為5.6662億美元，預計到2024年將達到5.8163億美元，複合年成長率為2.83%，到2030年將達到6.8931億美元。

心肺自動輸血系統 (CAS) 是一種專門的醫療設備，旨在在手術過程中抽取並回輸患者自身的血液，從而減少同種異體輸血的需要。這些系統在通常涉及大量失血的手術中發揮重要作用，例如心血管、整形外科和創傷手術。隨著對病人安全、成本控制和改善手術結果的重視，心血管疾病盛行率的增加、手術量的增加以及對血源性感染疾病和輸血相關併發症的認知的提高正在推動對CAS 的需求不斷成長。在多樣化的應用中，醫院、專科診所和門診手術中心是主要的最終用途領域，每個領域都在努力最佳化臨床效率和病人安全。

主要市場統計
基準年[2023] 5.6662 億美元
預測年份 [2024] 5.8163 億美元
預測年份 [2030] 68931萬美元
複合年成長率（%） 2.83%

市場成長要素包括 CAS 的技術進步、不斷發展的醫療基礎設施和政府對外科血液管理的支援政策。特別是在新興市場，隨著醫療保健投資的增加和先進醫療技術的普及。將 CAS 納入機器人手術、小型化系統以及開發攜帶式高效裝置可提供產品差異化和競爭優勢。然而，高昂的初始成本、嚴格的監管要求和複雜的程序是市場拓展的主要限制因素。此外，缺乏訓練有素的醫療保健專業人員來操作先進的自動輸血系統仍然是一個挑戰，特別是在發展中地區。

自動化裝置滅菌的創新、血液過濾機制的改進以及失血監測即時資料分析的結合可能會推動新的成長。此外，市場正在轉向以患者為中心的護理，重點是微創技術，並且有符合這些趨勢的創新空間。隨著產業的發展，與醫院系統和研究機構建立策略合作和夥伴關係可以確保持續成長。 CAS 市場充滿活力，持續的市場開拓表明，對於專注於血液管理解決方案尖端創新的現有企業和新參與企業來說，情況已經成熟。

市場動態：快速發展的心肺自動輸血系統市場的關鍵市場洞察

心肺機自動輸血系統市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 人口老化加劇和心血管手術數量增加
    • 醫療保健支出的增加和手術的進步
    • 血液儲存需求增加
  • 市場限制因素
    • 系統高成本且操作複雜
  • 市場機會
    • 自動化心肺機輸血系統的技術進步
    • 血液處理技術與先進過濾系統的創新
  • 市場挑戰
    • 對感染風險和污染問題的擔憂

波特五力：駕馭心肺自動輸血系統市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解心肺自動輸血系統市場的外部影響

外部宏觀環境因素在塑造心肺自動輸血系統市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解心肺自動輸血系統市場競爭狀況

對心肺自動輸血系統市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV定位矩陣心肺自動輸血系統市場供應商績效評估

FPNV 定位矩陣是評估心肺自動輸血系統市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製心肺自動輸血系統市場的成功之路

對心肺自動輸血系統市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人口老化加劇和心血管手術數量增加
      • 醫療保健成本上升和手術進步
      • 血液儲存需求增加
    • 抑制因素
      • 高成本、操作複雜度高
    • 機會
      • 自動化心肺機輸血系統的技術進步
      • 血液處理技術與先進過濾系統的創新
    • 任務
      • 對感染風險和污染問題的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章心肺自動輸血系統市場：依產品

  • 非體外循環輸血裝置
  • 體外循環輸血裝置

第7章自動心肺輸血系統市場：依應用分類

  • 心血管手術
  • 器官移植
  • 整形外科
  • 創傷治療

第8章心肺人工自動輸血系統市場：依最終使用者分類

  • 門診手術中心
  • 心臟研究中心
  • 醫院

第9章 北美和南美自動化心肺機輸血系統市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區自動心肺輸血系統市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲心肺自動輸血系統市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Advancis Surgical
  • Becton, Dickinson and Company
  • Beijing ZKSK Technology Co., Ltd.
  • Braile Biomedica
  • Brightwake Ltd.
  • Fresenius Kabi
  • Getinge AB
  • Global Blood Resources, LLC
  • LivaNova International
  • Medtronic PLC
  • ProCell Surgical
  • SARSTEDT
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Interventional Systems
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-69324464D30F

The Cardiopulmonary Autotransfusion Systems Market was valued at USD 566.62 million in 2023, expected to reach USD 581.63 million in 2024, and is projected to grow at a CAGR of 2.83%, to USD 689.31 million by 2030.

Cardiopulmonary Autotransfusion Systems (CAS) are specialized medical devices designed to collect and reinfuse a patient's own blood during surgical procedures, thereby reducing the need for allogeneic blood transfusions. These systems play a crucial role in surgeries that typically result in significant blood loss, such as cardiovascular, orthopedic, and trauma procedures. With a growing emphasis on patient safety, cost containment, and enhanced surgical outcomes, the necessity for CAS is intensified by the increasing prevalence of cardiovascular diseases, rising surgical volumes, and heightened awareness regarding blood-borne infections and transfusion-related complications. Across diverse applications, hospitals, specialty clinics, and ambulatory surgical centers represent key end-use segments, each keen on optimizing clinical efficiency and patient safety.

KEY MARKET STATISTICS
Base Year [2023] USD 566.62 million
Estimated Year [2024] USD 581.63 million
Forecast Year [2030] USD 689.31 million
CAGR (%) 2.83%

Market growth factors are bolstered by technological advancements in CAS, along with the evolving healthcare infrastructure and supportive government policies on surgical blood management. Opportunities lie particularly in emerging markets due to rising healthcare investments and expanding access to advanced medical technologies. Integrating CAS within robotic surgeries, miniaturization of systems, and developing portable, efficient units offer avenues for product differentiation and competitive advantage. However, high upfront costs, stringent regulatory requirements, and procedural complexities pose significant limitations to market expansion. Additionally, lack of trained healthcare professionals to operate sophisticated autotransfusion systems remains a challenge, particularly in developing regions.

Innovation in auto unit sterilization, refinement of blood filtering mechanisms, and incorporation of real-time data analytics for blood loss monitoring could foster new growth. Further, the market is shifting towards patient-centered care emphasizing minimally invasive techniques, offering room for innovations aligned with these trends. As the industry progresses, engaging in strategic collaborations and partnerships with hospital systems and research institutions could ensure sustainable growth. The CAS market is dynamic, with continuous developments signaling an evolving landscape ripe for both established players and new entrants focusing on cutting-edge innovations in blood management solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiopulmonary Autotransfusion Systems Market

The Cardiopulmonary Autotransfusion Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing aging population and increase in number of cardiac surgeries
    • Rising healthcare expenditure and advancements in surgical procedures
    • Increasing demand for blood conservation
  • Market Restraints
    • High cost of the system and operational complexity
  • Market Opportunities
    • Technological advancements in the cardiopulmonary autotransfusion systems
    • Innovations in the blood processing techniques and advanced filtration systems
  • Market Challenges
    • Concerns associated with infection risks and contamination issues

Porter's Five Forces: A Strategic Tool for Navigating the Cardiopulmonary Autotransfusion Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiopulmonary Autotransfusion Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiopulmonary Autotransfusion Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiopulmonary Autotransfusion Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiopulmonary Autotransfusion Systems Market

A detailed market share analysis in the Cardiopulmonary Autotransfusion Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiopulmonary Autotransfusion Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiopulmonary Autotransfusion Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiopulmonary Autotransfusion Systems Market

A strategic analysis of the Cardiopulmonary Autotransfusion Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiopulmonary Autotransfusion Systems Market, highlighting leading vendors and their innovative profiles. These include Advancis Surgical, Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biomedica, Brightwake Ltd., Fresenius Kabi, Getinge AB, Global Blood Resources, LLC, LivaNova International, Medtronic PLC, ProCell Surgical, SARSTEDT, Stryker Corporation, Teleflex Incorporated, Terumo Interventional Systems, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Cardiopulmonary Autotransfusion Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Off-Pump Transfusion Device and On-Pump Transfusion Device.
  • Based on Application, market is studied across Cardiac Surgery, Organ Transplant, Orthopedic Surgery, and Trauma Procedures.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Cardiac Research Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing aging population and increase in number of cardiac surgeries
      • 5.1.1.2. Rising healthcare expenditure and advancements in surgical procedures
      • 5.1.1.3. Increasing demand for blood conservation
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the system and operational complexity
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in the cardiopulmonary autotransfusion systems
      • 5.1.3.2. Innovations in the blood processing techniques and advanced filtration systems
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with infection risks and contamination issues
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiopulmonary Autotransfusion Systems Market, by Product

  • 6.1. Introduction
  • 6.2. Off-Pump Transfusion Device
  • 6.3. On-Pump Transfusion Device

7. Cardiopulmonary Autotransfusion Systems Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiac Surgery
  • 7.3. Organ Transplant
  • 7.4. Orthopedic Surgery
  • 7.5. Trauma Procedures

8. Cardiopulmonary Autotransfusion Systems Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Cardiac Research Centers
  • 8.4. Hospitals

9. Americas Cardiopulmonary Autotransfusion Systems Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cardiopulmonary Autotransfusion Systems Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cardiopulmonary Autotransfusion Systems Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advancis Surgical
  • 2. Becton, Dickinson and Company
  • 3. Beijing ZKSK Technology Co., Ltd.
  • 4. Braile Biomedica
  • 5. Brightwake Ltd.
  • 6. Fresenius Kabi
  • 7. Getinge AB
  • 8. Global Blood Resources, LLC
  • 9. LivaNova International
  • 10. Medtronic PLC
  • 11. ProCell Surgical
  • 12. SARSTEDT
  • 13. Stryker Corporation
  • 14. Teleflex Incorporated
  • 15. Terumo Interventional Systems
  • 16. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY OFF-PUMP TRANSFUSION DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY ON-PUMP TRANSFUSION DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY ORGAN TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023